Xavier Marinaro, MEng

Senior Consultant

View Xavier Marinaro's profile on LinkedIn

Xavier is a Senior Consultant with BSP whose engagements have focused primarily on the firm’s Business and Clinical Strategy and Health Economics practices. His recent projects with BSP include:

Business and Clinical Strategy:

  • Defined an optimized target product profile to support the adoption of a novel treatment for opioid addiction by analyzing the competitive landscape and evaluating the thoughts of key stakeholders
  • Conducted an opportunity assessment in the infectious disease diagnostic market space to support the viable launch of a novel diagnostic in both the US and EU markets
  • Evaluated the market opportunity for a novel LC-MS technology by identifying and interviewing key opinion leaders in the biomarker research space to determine current practices and unmet needs

Health Economics and Outcomes Research:

  • Determined the market size for a novel diagnostic device by leveraging culture data obtained from an electronic health record (EHR) database for several specific infectious disease states
  • Led SAS programming on retrospective cohort analysis comparing patient outcomes for patients receiving recombinant versus non-recombinant thrombin
  • Supported a claims database study on how different treatments of knee osteoarthritis impact opioid and corticosteroid injection use by implementing HCUP software to identify surgical procedures and CMS data, and crosswalk ICD9 codes to ICD10 codes
  • Developed proprietary algorithms to segment patients into clinically relevant subgroups for a variety of engagements that leveraged EHR data to conduct retrospective studies
    • KDIGO-AKI via ICD9/10 and biomarkers to compare albumin and saline in linear and logistical regression models
    • Planned vs. Unplanned readmission according to CMS guidelines via admission criteria
  • Leveraged EHR data to develop a budget impact model to demonstrate the potential hospital savings of adopting a client’s product that reduces the length of stay compared to current treatments

Medical Communications:

    • Enabled a biopharmaceutical client to reach a greater breadth and depth of key stakeholders by developing a conference planning tool to track relevant conferences by attendee type and conference subject to allow

Xavier graduated with a BS in Biological Engineering and an MEng in Biomedical Engineering from Cornell University. He also has a minor in Business Management, a Six Sigma Black Belt Certificate and a SAS Base Programming for SAS 9 Certificate. In his spare time, Xavier enjoys running and other sports.